altRX vs TrimRx
altRX has an open FDA warning letter dated June 8, 2026. TrimRx has none. On compounded tirzepatide injection, altRX costs $3,000 less a year at standing rates: $149 a month against $399 a month at TrimRx. It is one of four products the two sell at comparable terms.
To see where both sit among the other sellers, read our best weight-loss injection providers board.
The record
altRX / TrimRx
altRX
8.8/10
TrimRx
6.4/10
- RedRock Pharmacy503A
- Health Warehousetype not stated
- Precision Medicinetype not stated
- and 1 more
Both altRX and TrimRx are affiliate partners: we are paid if you sign up through our links. Neither is featured. Scores are computed the same way for both (altRX 8.8, TrimRx 6.4). How we are paid
What the record shows
- 01
altRX has an open FDA warning letter dated June 8, 2026. TrimRx has none.
- 02
altRX names four pharmacies. TrimRx names no compounding pharmacy in our record.
- 03
On compounded tirzepatide injection, altRX costs $3,000 less a year at standing rates: $149 a month against $399 a month at TrimRx. It is one of four products the two sell at comparable terms.
- 04
altRX lists all 50 states. TrimRx publishes no state list.
Prices and terms, product by product
A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.
altRX
TrimRx
$89/moLower
$1,068 a year
$299/mo
$3,588 a year
$149/moLower
$1,788 a year
$399/mo
$4,788 a year
$1,149/moLower
$13,788 a year
$1,299/mo
$15,588 a year
$1,249/moLower
$14,988 a year
$1,399/mo
$16,788 a year
Read off each seller’s own pages. altRX: September 28, 2026. TrimRx: October 25, 2026. Every plan and dose we hold is on the full review.
The case for each
The case for altRX
8.8/10- $2,520 a year less on compounded semaglutide injection
- $3,000 a year less on compounded tirzepatide injection
- Names its compounding pharmacy
- Open FDA warning letter, June 8, 2026
The case for TrimRx
6.4/10- No FDA warning letter on record
- Names no compounding pharmacy
- Publishes no state list
Scores
altRX 8.8 · TrimRx 6.4 out of 10. Six weighted parts.
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
The score is the same formula for every seller. Payment does not enter it. Method
altRX vs TrimRx: questions
Other sellers we are paid by
Affiliate partners outside this pair. Each has its own record and review, scored the same way.
- Direct Meds7.1
From $249/mo
Visit site - SnagRx9.2
From $99/mo
Visit site - RxSpan MD7.9
From $249/mo
Visit site
Sellers closest to these two
Matched on molecule, form and price. Every pair we list · The register
Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks